Chemokines: New, key players in the pathobiology of pancreatic cancer

International Journal of Gastrointestinal Cancer

Volumn 31, Issue 1-3, 2002, Pages 23-29

  Hedin, Karen E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cancer; Chemokines; G proteins; Pancreas; Signaling

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; EOTAXIN; FRACTALKINE; G PROTEIN COUPLED RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0036943187     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:31:1-3:23     Document Type: Review

References (39)

1. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002;2:106-115.
2. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001;14:377-386.
3. Thelen M. Dancing to the tune of chemokines. Nat Immunol 2001;2:129-134.
4. Cascieri MA, Springer MS. The chemokine/chemokinereceptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000;4:420-427.
5. Marinissen MJ, Gutkind JS. G protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001;22:368-376.
6. Arenberg DA, Polverini PJ, Kunkel SL, et al. The role of CXC chemokines in the regulation of angiogenesis in nonsmall cell lung cancer. J Leukocyte Biol 1997;62:554-562.
7. Hunter T. Oncoprotein Networks. Cell 1997;88:333-346.
8. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1-17.
9. Moore BB, Keane MP, Addison CL, Arenberg DA, Strieter RM. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Invest Med 1998;46:113-120.
10. Murphy PM. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2002;2:116-122.
11. Rowland-Jones S, Pinheiro S, Kaul R. New insights into host factors in HIV-1 pathogenesis. Cell 2001;104:473-476.
12. Whitehead IP, Zohn IE, Der CJ. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 2001;20:1547-1555.
13. Dhanasekaran N, Tsim S-T, Dermott JM, Onesime D. Regulation of cell proliferation by G proteins. Oncogene 1998;17:1383-1394.
14. Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of Stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000;6:3530-3535.
15. Kleeff J, Kusama T, Rossi DL, et al. Detection and localization of MIP-3α/LARC/EXODUS, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999;81:650-657.
16. Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR-1/2 activate Mitogen-activated protein kinase via the Epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 2000;275:6868-6875.
17. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
18. Nesbit M, Schaider H, Miller TH, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001;166:6483-6490.
19. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis thorugh stromal cell-derived factor-1. Blood 2000;96:2655-2663.
20. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-4689.
21. Urrutia R, Dimagno EP. Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? Gastroenterology 1996;110:306-310.
22. Suzuki Y, Rahman M, Mitsuya H. Diverse transcriptional response of CD4+ T cells to Stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4+ T cells. J Immunol 2001;167:3064-3073.
23. Driessens MHE, van Rijthoven EAM, Riviere GL, Roos E. Expression of a pertussis toxin adenosine diphosphateribosyltransferase in a T-cell hybridoma reduces metastatic capacity. Blood 1996;88:3116-3123.
24. Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B 16 murine melanoma. J Natl Cancer Inst 2001;93:1638-1643.
25. Chung CY, Funamoto S, Irtel RA. Signaling pathways controlling cell polarity and chemotaxis. Trends Biol Sci 2001;26:557-566.
26. Carmeleit P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
27. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
28. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-89.
29. Yang T-Y, Chen S-C, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by Human Herpesvirus 8 induces an angioproliferative disease resembling Kaposi's Sarcoma. J Exp Med 2000;191:445-453.
30. Kumamoto T, Huang EK, Paek HJ, Morita A, Matsue H, Valentini RF, Takashima A. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat Biotechnol 2002;20:64-69.
31. Nomura T, Hasegawa H, Kohno M, Sasaki M, Fujita S. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue EBI-1-ligand chemokine and stromal cell-derived factor-1 alpha chemokine genes. J Leukocyte Biol 2001;91:597-606.
32. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545.
33. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1422-1437.
34. Saurer L, Reber P, Schaffner T, Buchler MW, Buri C, Kappeler A, Walz A, Friess H, Mueller C. Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-367.
35. Sebastiano PD, di Mola FF, Febbo CD, et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000;47:423-428.
36. Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-1975.
37. Barber MD, Powell JJ, Lynch SF, Fearon KCH, Ross JA. A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer. Br J Cancer 2000;83:1443-1447.
38. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001;357:1758-1761.
39. Moatti D, Faure S, Fumeron F, et al. Polymorphism in the fractalkine receptor CX3CRI as a genetic risk factor for coronary artery disease. Blood 2001;97:1925-1928.